RxDoctor Payments Data

Anna Lizama Clark

Obstetrics & Gynecology · Dallas, TXNPI 1346337888

Payments from drug & device makers

What this record shows

Pfizer accounts for 74.5% of it on its own, with 5 other manufacturers making up the rest.

$2,189in general payments, 2019–2025

Across 10 payments — averaging $218.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$2K
  • Integra Lifesciences Corporation$144
  • Alkermes, Inc.$142
  • Neurocrine Biosciences, Inc.$125
  • Gilead$122
  • Exact Sciences$26
$888,321in research payments, 2019–2025

Across 351 payments — averaging $2530.83 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$391K
  • Pfizer$151K
  • Evofem Biosciences, Inc.$87K
  • Ironwood Pharmaceuticals, Inc$76K
  • Amgen$64K
  • Merck$60K
  • plus $60K from 3 others

What the payments were for

  • Travel & lodging$1,28259%
  • Food & beverage$90741%

General payments by program year

19
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,189 in reported general payments places this provider in the 65th percentile of 3,099 obstetrics & gynecology providers in Texas.

See all obstetrics & gynecology providers in Texas

Other obstetrics & gynecology in Dallas

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →